Naoki Miyamoto

1.6k total citations
61 papers, 1.3k citations indexed

About

Naoki Miyamoto is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Organic Chemistry. According to data from OpenAlex, Naoki Miyamoto has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Electrical and Electronic Engineering and 8 papers in Organic Chemistry. Recurrent topics in Naoki Miyamoto's work include Semiconductor materials and devices (10 papers), Advanced Data Storage Technologies (6 papers) and Advancements in Semiconductor Devices and Circuit Design (6 papers). Naoki Miyamoto is often cited by papers focused on Semiconductor materials and devices (10 papers), Advanced Data Storage Technologies (6 papers) and Advancements in Semiconductor Devices and Circuit Design (6 papers). Naoki Miyamoto collaborates with scholars based in Japan, Switzerland and South Korea. Naoki Miyamoto's co-authors include Shinichi Imamura, Hiroshi Miki, V. Cingoski, Hideo Yamashita, Hidehisa Iwata, Akira Hori, Kazunobu Toshima, Shuichi Matsumura, Yuya Oguro and Masaki Seto and has published in prestigious journals such as Nature Communications, Chemical Communications and Scientific Reports.

In The Last Decade

Naoki Miyamoto

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Miyamoto Japan 21 531 457 215 190 117 61 1.3k
Zhimin Zhang China 18 688 1.3× 154 0.3× 206 1.0× 90 0.5× 176 1.5× 75 1.6k
Makoto Miyamoto Japan 21 300 0.6× 196 0.4× 136 0.6× 110 0.6× 40 0.3× 137 1.4k
William L. Scott United States 23 600 1.1× 622 1.4× 85 0.4× 91 0.5× 31 0.3× 70 1.4k
Can Cai China 19 997 1.9× 75 0.2× 341 1.6× 197 1.0× 54 0.5× 41 2.5k
Kazuhiro Takeuchi Japan 22 248 0.5× 89 0.2× 65 0.3× 503 2.6× 13 0.1× 190 1.7k
Yoshikazu Fujimori Japan 18 262 0.5× 91 0.2× 71 0.3× 364 1.9× 13 0.1× 74 1.3k
Masakazu Sato Japan 13 226 0.4× 124 0.3× 49 0.2× 147 0.8× 7 0.1× 90 943
Xilu Wang United States 14 544 1.0× 193 0.4× 124 0.6× 31 0.2× 23 0.2× 35 997
Yunli Zhang China 17 269 0.5× 54 0.1× 72 0.3× 314 1.7× 10 0.1× 112 1.2k
Yasushi Kubota Japan 23 482 0.9× 217 0.5× 104 0.5× 337 1.8× 159 1.4× 130 1.6k

Countries citing papers authored by Naoki Miyamoto

Since Specialization
Citations

This map shows the geographic impact of Naoki Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Miyamoto more than expected).

Fields of papers citing papers by Naoki Miyamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Miyamoto. The network helps show where Naoki Miyamoto may publish in the future.

Co-authorship network of co-authors of Naoki Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Miyamoto. A scholar is included among the top collaborators of Naoki Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Miyamoto. Naoki Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kwon, Haw‐Young, Amit Sharma, Sun Hyeok Lee, et al.. (2022). Visualizing inflammation with an M1 macrophage selective probe via GLUT1 as the gating target. Nature Communications. 13(1). 5974–5974. 45 indexed citations
3.
Osuka, Koichi, et al.. (2017). Development of a small and lightweight myriapod robot using passive dynamics. Artificial Life and Robotics. 22(4). 429–434. 11 indexed citations
4.
5.
Kunimatsu, Jun, Naoki Miyamoto, Masayori Ishikawa, Hiroki Shirato, & Masaki Tanaka. (2015). Application of radiosurgical techniques to produce a primate model of brain lesions. Frontiers in Systems Neuroscience. 9. 67–67. 5 indexed citations
6.
Miyamoto, Naoki & Kiyoshi Ohishi. (2013). Correction Method of Current Measurement Error caused by Offset and Gain Deviation of Current Sensor for SPMSM. IEEJ Transactions on Industry Applications. 133(6). 627–638. 3 indexed citations
7.
Nakamura, Kazuhide, Akio Mizutani, Hidehisa Iwata, et al.. (2013). A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of In Vivo Antitumor Activities. Molecular Cancer Therapeutics. 12(6). 913–924. 27 indexed citations
8.
9.
Matsumoto, Shigemitsu, Naoki Miyamoto, Takaharu Hirayama, et al.. (2013). Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 21(24). 7686–7698. 48 indexed citations
10.
Oguro, Yuya, Douglas R. Cary, Naoki Miyamoto, et al.. (2013). Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: Discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics. Bioorganic & Medicinal Chemistry. 21(15). 4714–4729. 38 indexed citations
11.
Miyamoto, Naoki, Nozomu Sakai, Takaharu Hirayama, et al.. (2013). Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Bioorganic & Medicinal Chemistry. 21(8). 2333–2345. 64 indexed citations
13.
Oguro, Yuya, Naoki Miyamoto, Terufumi Takagi, et al.. (2010). N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases. Bioorganic & Medicinal Chemistry. 18(20). 7150–7163. 26 indexed citations
14.
Oguro, Yuya, Naoki Miyamoto, Kengo Okada, et al.. (2010). Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorganic & Medicinal Chemistry. 18(20). 7260–7273. 95 indexed citations
15.
Seto, Masaki, Naoki Miyamoto, Katsuji Aikawa, et al.. (2004). Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety. Bioorganic & Medicinal Chemistry. 13(2). 363–386. 82 indexed citations
16.
Tanaka, Masatoshi, et al.. (2002). Driver's Fatigue Evaluation During Long Term Driving for Automotive Seat Development. SAE technical papers on CD-ROM/SAE technical paper series. 1. 12 indexed citations
18.
Takahashi, Hideo, et al.. (1996). A Case of Postoperative Bile Duct Stone by Aberrant Surgical Clip after Laparoscopic Cholecystectomy.. The Japanese Journal of Gastroenterological Surgery. 29(1). 85–88. 2 indexed citations
19.
20.
Miyamoto, Naoki, et al.. (1991). Influence of Mode of Delivery on Fetal Pituitary‐Thyroid Axis. Pediatrics International. 33(3). 363–368. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026